Stereotactic Ventral Pallidotomy for Parkinson's Disease
Neurol 45:753-761, Dogali,M.,et al, 1995
Parkinsonism Unmasked by Lovastatin
Ann Neurol 37:685-686, Muller,T.,et al, 1995
Psychogenic Parkinsonism
Arch Neurol 52:802-810, Lang,A.E.,et al, 1995
Panic Attacks and Panic Disorder:The Great Neurologic Imposters
Semin Neurol 15:126-132, Stahl,S.M.&Soefje,S., 1995
"Rubral"Tremor due to Midbrain Toxoplasma Abscess
Movement Disorders 5:254-256, Koppel,B.S.&Daras,M., 1995
Hereditary Adult-Onset Alexander's Disease with Palatal Myoclonus, Spastic Paraparesis and Cerebellar Ataxia
Neurol 45:2266-2271, Schwankhaus,J.D.,et al, 1995
Management of Acoustic Neuroma
BMJ 311:1141-1144, Wright,A.&Bradford,R., 1995
Psychogenic Movement Disorders:Frequency, Clinical Profile and Characteristics
JNNP 59:406-412, Factor,S.A.,et al, 1995
Disabling Parkinsonism Due to Lithium: A Case Report
J Geriatr Psychiatry Neurol 8:118-119, Holroyd,S. & Smith,D., 1995
Zinc-Induced Deterior in Wilson's Disease Aborted by Trtm with Penicillamine, Dimercaprol, & A Novel Zero Copper Diet
Arch Neurol 52:10-11, Walshe,J.M.,et al, 1995
Primary Orthostatic Tremor
BMJ 310:143-144, Britton,T.C.&Thompson,P.D., 1995
Effect on Parkinsonian Signs and Symptoms of Bilateral Subthalamic Nucleus Stimulation
Lancet 345:91-95, Limousin,P.,et al, 1995
A Positron Emission Tomography Study of Cerebral Activation Associated with Essential and Writing Tremor
Arch Neurol 52:299-305, Wills,A.J.,et al, 1995
A Novel Mutation in Exon 3 of the Proteolipid Protein Gene in Pelizaeus-Merzabacher Disease
Neurol 45:394-395, Pratt,V.M.,et al, 1995
Involuntary Movement Disorders Associated with Felbamate
Neurol 45:185-187, Kerrick,J.M.,et al, 1995
The Shaken Infant Syndrome
BMJ 310:344-345, Carty,H.&Ratcliffe,J., 1995
MRI of the Brain in Wilson Disease:T2 Signal Loss Under Therapy
J Comput Assist Tomogr 19:635-638, Engelbrecht,V.,et al, 1995
Kayser-Fleischer Ring:Hepatolenticular Degeneration (Wilson's Disease)
Neurol 45:1261-1262, Finelli,P.F., 1995
Botulinum Toxin Treatment of Essential Head Tremor
Neurol 45:822-824, Pahwa,R.,et al, 1995
The Effect of Nimodipine on Essential Tremor
Neurol 45:1523-1525, Biary,N.,et al, 1995
Neuroleptic Drug Exposure and Treatment of Parkinsonism in the Elderly:A Case-Control Study
Am J Med 99:48-54, Avorn,J.,et al, 1995
Speech Motor Control Disorder after HIV Infection
Neurol 44:2187-2189, Lopez,O.L.,et al, 1994
Oral and Genital Tardive Pain Syndromes
Neurol 44:2115-2119, Ford,B.,et al, 1994
Post-Traumatic Movement Disorders:Central and Peripheral Mechanisms
Neurol 44:2006-2014, Jankovic,J., 1994
Writing Tremor After Discrete Cortical Infarction
Stroke 25:2280-2282, Kim,J.S.&Myoung,C.L., 1994
Worsening of Neurologic Syndrome in Patients with Wilson's Disease with Initial Penicillamine Therapy
Arch Neurol 44:490-493, Brewer,G.J.,et al, 1994
Evidence for Long-Term Survival and Function of Dopaminergic Grafts in Progressive Parkinson's Disease
Ann Neurol 35:172-180, Lindvall,O.,et al, 1994
Development of Neurologic Symptoms in a Patient with Asymptomatic Wilson's Disease Treated with Penicillamine
Arch Neurol 51:304-305, Brewer,G.J.,et al, 1994
Myoclonus Associated with Propafenone
BMJ 308:113, Chua,T.P.,et al, 1994
The Thalamic Ataxia Syndrome
Neurol 44:810-814, Solomon,D.H.,et al, 1994
Cocaine-Induced Choreoathetoid Movements ('Crack Dancing')
Neurol 44:751-752, Daras,M.,et al, 1994
Treatment of Wilson's Disease with Ammonium Tetrathiomolybdate
Arch Neurol 51:545-554, Brewer,G.J.,et al, 1994
Initial and Follow-up Brain MRI Findings and Correlation with the Clinical Course in Wilson's Disease
Neurol 44:1064-1068, Roh,J.K.,et al, 1994
Treatment with D-penicillamine Improves Dopamine D2-Receptor Binding and T2-Signal Intensity in de novo Wilson's Disease
Neurol 44:1079-1082, Schwarz,J.,et al, 1994
The Relationship of Essential Tremor to Other Movement Disorders:Report on 678 Patients
Ann Neurol 35, 717-7231994., Koller,W.C.,et al, 1994
Clinical Assessment of Extrapyramidal Signs in Nursing Home Patients Given Antipsychotic Medication
Arch Int Med 154:1113-1117, Avorn,J.,et al, 1994
Reversal of Amphotericin-B-Related Encephalopathy
Neurol 44:1183-1184, Balmaceda,C.M.,et al, 1994
Four-Year Follow-up of Adrenal-to-Brain Transplants in Parkinson's Disease
Arch Neurol 51:559-563, Diamond,S.G.,et al, 1994
Parkinson's Disease
JNNP 57:672-681, Marsden,C.D., 1994
Parkinsonism Induced by Solvent Abuse
Ann NEurol 35:616-618, Uitti,R.J.,et al, 1994
Parkinsonism Caused by Petroleum Waste Ingestion
Neurol 44:1051-1054, Tetrud,J.W.,et al, 1994
Spectrum of Lateral Medullary Syndrome:Correlation Between Clinical Findings and Magnetic Resonance Imaging in 33 Subjects
Stroke 25:1405-1410, Kim,J.S.,et al, 1994
Choreiform Movements Associated with the Use of Valproate
Arch Neurol 51:702-704, Lancman,M.E.,et al, 1994
Frequency and Pathogenesis of Hemodynamic Stroke
Stroke 25:2179-2182, Bladin,C.F.&Chambers,B.R., 1994
Acute Spinal Subdural Hematoma:MR and CT Findings with Pathologic Correlates
AJNR 15:1895-1905, Donovan Post,M.J.,et al, 1994
Wilson's Disease:Evidence of Subgroups Derived from Clinical Findings and Brain Lesions
Neurol 43:120-124, Oder,W.,et al, 1993
Neurosurgical Horizons in Parkinson's Disease
Neurol 43:1-7, Goetz,C.G.,et al, 1993
Increase of Parkinson Disability after Fluoxetine Medication
Neurol 43:211-213, Steur,E.N.H.J., 1993
Nigral Dysfunction in Drug-Induced Parkinsonism:An F-dopa PET Study
Neurol 43:552-556, Burn,D.J.&Brooks,D.J., 1993
Tardive Stereotype and Other Movement Disorders in Tardive Dyskinesias
Neurol 43:937-941, Stacy,M.,et al, 1993